Spoken Alpha
PHAR
Pharming Group N.V.
Overview
Pharming Group N.V is a Healthcare company operating in Biotechnology with a $909.2M market cap.
Most recent earnings call: Q1 FY26 on May 7, 2026.
17 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-079 Q&A exchanges
- Q3 FY2025Earnings2025-11-066 Q&A exchanges
- Q2 FY2025Earnings2025-08-016 Q&A exchanges
- Q1 FY2025Earnings2025-05-0911 Q&A exchanges
- Q4 FY2024Earnings2025-03-1315 Q&A exchanges
- Q3 FY2024Earnings2024-10-2421 Q&A exchanges
- Q2 FY2024Earnings2024-08-027 Q&A exchanges
- Q1 FY2024Earnings2024-05-1220 Q&A exchanges
- Q4 FY2023Earnings2024-03-1423 Q&A exchanges
- Q3 FY2023Earnings2023-10-2726 Q&A exchanges
- Q2 FY2023Earnings2023-08-0622 Q&A exchanges
- Q1 FY2023Earnings2023-05-1110 Q&A exchanges
- Q4 FY2022Earnings2023-03-1622 Q&A exchanges
- Q3 FY2022Earnings2022-10-2910 Q&A exchanges
- Q1 FY2022Earnings2022-05-159 Q&A exchanges
- Q3 FY2021Earnings2021-10-299 Q&A exchanges
- Q2 FY2021Earnings2021-08-0816 Q&A exchanges
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Track Record
SampleSpoken Alpha tracks PHAR's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.63 | $3.21 | +13.2% | +2.2% | +3.5% |
| Q4 FY2026 | $3.99 | $3.28 | +21.6% | +7.3% | +8.0% |
| Q3 FY2026 | $4.09 | $3.37 | +21.4% | +9.2% | +11.1% |
| Q2 FY2026 | $3.85 | $3.26 | +18.0% | -1.6% | +0.2% |
| Q1 FY2025 | $3.78 | $3.40 | +11.3% | -1.3% | 0.0% |
| Q4 FY2025 | $3.84 | $3.28 | +17.2% | +4.9% | +6.4% |
| Q3 FY2025 | $4.02 | $3.38 | +19.0% | +3.4% | +1.9% |
| Q2 FY2025 | $4.03 | $3.36 | +20.0% | +6.4% | +5.2% |
| Q1 FY2024 | $4.41 | $3.57 | +23.4% | +6.7% | +6.2% |
| Q4 FY2024 | $4.03 | $3.45 | +16.8% | -1.1% | -3.6% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PHAR.
$ curl https://api.spokenalpha.com/v1/companies/PHARFAQ
Frequently asked about PHAR
Where can I find Pharming Group N.V.'s (PHAR) earnings call transcripts?
Spoken Alpha indexes PHAR's earnings call transcripts at https://spokenalpha.com/companies/PHAR. Each call links to attributed speakers and parsed analyst Q&A. Pharming Group N.V.'s own investor relations page is at https://www.pharming.com/investors.
When was Pharming Group N.V.'s most recent earnings call?
Pharming Group N.V. (PHAR) held its most recent earnings call on 2026-05-07, covering fiscal Q1 2026.
What sector is PHAR in?
Pharming Group N.V. (PHAR) operates in the Healthcare sector (Biotechnology industry).